NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

180 Life Sciences Corp (NASDAQ: ATNF)

 
ATNF Technical Analysis
4
As on 15th Aug 2025 ATNF SHARE Price closed @ 7.04 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.18 & Strong Buy for SHORT-TERM with Stoploss of 2.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ATNFSHARE Price

Open 6.85 Change Price %
High 7.24 1 Day -0.57 -7.49
Low 6.29 1 Week 3.46 96.65
Close 7.04 1 Month 6.16 700.00
Volume 11103189 1 Year 6.84 3420.00
52 Week High 10.70 | 52 Week Low 0.20
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
OPEN 3.17 4.28%
INTC 24.56 2.93%
PGEN 2.94 58.92%
NVDA 180.45 -0.86%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
PPSI 4.35 39.87%
TLRY 1.03 -12.71%
CODX 0.29 7.41%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
SRAX 0.05 150.00%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.05 -58.33%
MILEW 0.06 -53.85%
 
 
ATNF
Daily Charts
ATNF
Intraday Charts
Whats New @
Bazaartrend
ATNF
Free Analysis
 
ATNF Important Levels Intraday
RESISTANCE8.87
RESISTANCE8.28
RESISTANCE7.92
RESISTANCE7.56
SUPPORT6.52
SUPPORT6.16
SUPPORT5.80
SUPPORT5.21
 
ATNF Forecast August 2025
4th UP Forecast11.61
3rd UP Forecast10.14
2nd UP Forecast9.24
1st UP Forecast8.33
1st DOWN Forecast5.75
2nd DOWN Forecast4.84
3rd DOWN Forecast3.94
4th DOWN Forecast2.47
 
ATNF Weekly Forecast
4th UP Forecast9.04
3rd UP Forecast8.40
2nd UP Forecast8.00
1st UP Forecast7.61
1st DOWN Forecast6.47
2nd DOWN Forecast6.08
3rd DOWN Forecast5.68
4th DOWN Forecast5.04
 
ATNF Forecast2025
4th UP Forecast39.97
3rd UP Forecast29.41
2nd UP Forecast22.88
1st UP Forecast16.35
1st DOWN Forecast-2.27
2nd DOWN Forecast-8.8
3rd DOWN Forecast-15.33
4th DOWN Forecast-25.89
 
 
ATNF Other Details
Segment EQ
Market Capital 173528464.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ATNF Address
ATNF
 
ATNF Latest News
 
Your Comments and Response on 180 Life Sciences Corp
 
ATNF Business Profile
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California. Address: 3000 El Camino Real, Palo Alto, CA, United States, 94306
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service